Delhi High Court · 2026-04-28
MULTANI PHARMACEUTICALS LIMITED vs MAYURI BHUPAL BHAMARE
- Citation / case number
- CS(COMM)-934/2024 2026:DHC:3575
- Court
- Delhi High Court
- Petitioner
- MULTANI PHARMACEUTICALS LIMITED
- Respondent
- MAYURI BHUPAL BHAMARE
Judgment text excerpt
$~ * IN THE HIGH COURT OF DELHI AT NEW DELHI % Date of Decision: 28th April, 2026 + CS(COMM) 934/2024 and I.A. 43164/2024 MULTANI PHARMACEUTICALS LIMITED .....Plaintiff Through: Mr. Pravin Anand and Mr. Ashutosh Upadhyay, Advocates. versus MAYURI BHUPAL BHAMARE .....Defendant Through: Ms. Nupoor Maharaj, Advocate. CORAM: HON'BLE MS. JUSTICE JYOTI SINGH JUDGEMENT JYOTI SINGH, J. 1. This suit is instituted on behalf of the Plaintiff inter alia seeking a decree of permanent injunction restraining the Defendant and all others acting on its behalf from selling, exporting, offering for sale, advertising, manufacturing the impugned products in any manner whatsoever or using the impugned marks MULTANI/ / and/or any other mark identical or deceptively similar to Plaintiff’s registered trademarks MULTANI/ (Multani)/ / Signature Not Verified Digitally Signed By:KAMAL KUMAR CS(COMM) 934/2024 Page 1 of 14 Signing Date:29.04.2026 15:01:04 / , amounting to infringement of trademarks and/or passing off. 2. As stated in the plaint, Plaintiff originally started as a small clinic run by its founder in 1905 and in 1938, Multani Pharmacy was formally established and Plaintiff launched its first ever product MULTANI KUKA TABLETS. Plaintiff company was incorporated on 05.03.1986, originally as Multani Pharmaceuticals Pvt. Ltd., whereafter pursuant to special Resolution dated 02.08.1995, the name was changed to Multani Pharmaceuticals Limited. Plaintiff has been involved in manufacture and distribution of Ayurvedic, Unani and herbal medicines and is a research oriented organization driven by a constant endeavour to produce safe, efficacious and consistent remedies using Ayurvedic principles and over the years, through continuous and rigorous research, Plaintiff has successfully developed sever